154 related articles for article (PubMed ID: 29254795)
21. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.
Amary F; Berisha F; Ye H; Gupta M; Gutteridge A; Baumhoer D; Gibbons R; Tirabosco R; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2017 Aug; 41(8):1059-1068. PubMed ID: 28505000
[TBL] [Abstract][Full Text] [Related]
22. [H3F3A mutated multicentric giant cell tumor of bone : A very rare primary bone disease].
Giesche JP; von Baer A; Breining T; Marienfeld R; Mellert K; Lüke J; Schultheiss M; Möller P; Barth TFE
Pathologe; 2018 Sep; 39(5):451-456. PubMed ID: 30046846
[TBL] [Abstract][Full Text] [Related]
23. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
[TBL] [Abstract][Full Text] [Related]
24. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
Noh BJ; Park YK
Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971
[TBL] [Abstract][Full Text] [Related]
25. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.
Behjati S; Tarpey PS; Presneau N; Scheipl S; Pillay N; Van Loo P; Wedge DC; Cooke SL; Gundem G; Davies H; Nik-Zainal S; Martin S; McLaren S; Goodie V; Robinson B; Butler A; Teague JW; Halai D; Khatri B; Myklebost O; Baumhoer D; Jundt G; Hamoudi R; Tirabosco R; Amary MF; Futreal PA; Stratton MR; Campbell PJ; Flanagan AM
Nat Genet; 2013 Dec; 45(12):1479-82. PubMed ID: 24162739
[TBL] [Abstract][Full Text] [Related]
26. Symplastic/pseudoanaplastic giant cell tumor of the bone.
Sarungbam J; Agaram N; Hwang S; Lu C; Wang L; Healey J; Hameed M
Skeletal Radiol; 2016 Jul; 45(7):929-35. PubMed ID: 27020452
[TBL] [Abstract][Full Text] [Related]
27. [New aspects on giant cell tumor of bone].
Lüke J; Hasenfratz M; Möller P; Barth TFE
Pathologe; 2018 Mar; 39(2):125-131. PubMed ID: 29110035
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics.
Presneau N; Baumhoer D; Behjati S; Pillay N; Tarpey P; Campbell PJ; Jundt G; Hamoudi R; Wedge DC; Loo PV; Hassan AB; Khatri B; Ye H; Tirabosco R; Amary MF; Flanagan AM
J Pathol Clin Res; 2015 Apr; 1(2):113-23. PubMed ID: 27499898
[TBL] [Abstract][Full Text] [Related]
29. The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws.
Gomes CC; Diniz MG; Amaral FR; Antonini Guimarães BV; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):583-5. PubMed ID: 25442495
[TBL] [Abstract][Full Text] [Related]
30. [DNA sequencing of H3F3A mutations in H3.3 immunohistochemistry-negative giant cell tumors of bone].
Gong LH; Zhang W; Sun XQ; Zhang M; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):190-193. PubMed ID: 33677880
[No Abstract] [Full Text] [Related]
31. Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone.
Gamberi G; Benassi MS; Ragazzini P; Pazzaglia L; Ponticelli F; Ferrari C; Balladelli A; Mercuri M; Gigli M; Bertoni F; Picci P
Ann Oncol; 2004 Mar; 15(3):498-503. PubMed ID: 14998856
[TBL] [Abstract][Full Text] [Related]
32. Giant cell tumor of soft tissue of the breast: Case report with H3F3A mutation analysis and review of the literature.
Luangxay T; Osako T; Yonekura R; Sugiura Y; Kikuchi M; Gomi N; Ueno T; Ohno S; Machinami R; Takeuchi K; Akiyama F
Pathol Res Pract; 2020 Feb; 216(2):152750. PubMed ID: 31784095
[TBL] [Abstract][Full Text] [Related]
33. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation.
Tsukamoto Y; Futani H; Kihara T; Watanabe T; Kumanishi S; Matsuo S; Hirota S; Ueda T; Yamamoto H; Yoshiya S
Pathol Res Pract; 2018 Sep; 214(9):1504-1509. PubMed ID: 29970305
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy.
Rehkämper J; Steinestel K; Jeiler B; Elges S; Hekeler E; Huss S; Sperveslage J; Hardes J; Streitbürger A; Gosheger G; Wardelmann E; Baumhoer D; Trautmann M; Hartmann W
Oncotarget; 2018 Jul; 9(53):30106-30114. PubMed ID: 30046391
[TBL] [Abstract][Full Text] [Related]
35. [The study of the value of H3F3A G34W immunohistochemical staining in the diagnosis of giant cell tumor of bone].
Bai YQ; Yang TT; Zhang HZ
Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):531-536. PubMed ID: 31288308
[No Abstract] [Full Text] [Related]
36. Histone Mutations and Bone Cancers.
Taylor EL; Westendorf JJ
Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
[TBL] [Abstract][Full Text] [Related]
37. Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.
Venneker S; Szuhai K; Hogendoorn PCW; Bovée JVMG
Virchows Arch; 2020 Jan; 476(1):135-146. PubMed ID: 31728625
[TBL] [Abstract][Full Text] [Related]
38. Chondroblastoma: An Update.
Chen W; DiFrancesco LM
Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Utility of Genetic and Immunohistochemical
Wągrodzki M; Tysarowski A; Seliga K; Wojnowska A; Stepaniuk M; Castañeda Wysocka P; Makuła D; Pieńkowski A; Szostakowski B; Zub R; Rutkowski P
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055156
[TBL] [Abstract][Full Text] [Related]
40. Giant cell tumor of bone with H3F3B mutation: A case report.
Wu R; Wu X; Weng X; Xiu Y; Xu G; Liu X; Liu X
Medicine (Baltimore); 2023 Feb; 102(7):e32995. PubMed ID: 36800629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]